ArticleThe Journal of infectious diseases2024

Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance Mutations.

Shuntai Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.